Artivion Dividends and Buybacks
Dividend criteria checks 0/6
Artivion does not currently pay a dividend.
Key information
0%
Dividend yield
-0.5%
Buyback Yield
| Total Shareholder Yield | -0.5% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | US$0.120 |
| Payout ratio | 0% |
Recent dividend and buyback updates
No updates
Recent updates
When Should You Buy Artivion, Inc. (NYSE:AORT)?
Nov 07
Returns At Artivion (NYSE:AORT) Are On The Way Up
Sep 28Estimating The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)
Sep 06Is Artivion (NYSE:AORT) A Risky Investment?
Jun 28Data-Driven Growth Fuels More Upside For Overlooked Artivion
Jun 21Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
May 08Is Artivion (NYSE:AORT) Using Too Much Debt?
Jan 13Artivion Stock: A First Assessment
Dec 27Investors Still Aren't Entirely Convinced By Artivion, Inc.'s (NYSE:AORT) Revenues Despite 27% Price Jump
Nov 23Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025
Oct 13Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade)
Jul 20Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
May 10Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet
Mar 09Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M
Feb 16Artivion: PROACT Xa Overhang Remains Well In Situ, Reaffirm Hold
Dec 18Artivion (NYSE:AORT) Is Making Moderate Use Of Debt
Sep 29Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver
Sep 27Artivion Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $80.34M beats by $3.07M
Aug 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if AORT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AORT's dividend payments have been increasing.
Dividend Yield vs Market
| Artivion Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AORT) | 0% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.4% |
| Industry Average (Medical Equipment) | 1.7% |
| Analyst forecast (AORT) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate AORT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AORT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: AORT is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as AORT has not reported any payouts.